TGen, Arizona’s new Translational Genomics Research Institute, has filled out its staff with 23 additional scientists, research assistants, and technicians, according to a company spokeswoman.
Four of these scientists — Michael Bittner, Spyro Mousses, Pamela Pollock, and Jeff Touchman — come from the NHGRI, where TGen director Jeffrey Trent was scientific director before leaving last June.
Bittner has been appointed senior research investigator in bioinformatics and will use informatics to study cell pathogenesis in silico.
Mousses will run TGen’s cancer drug-development laboratory. He has published recently on the use of microarrays for gene-expression analysis in prostate cancer and prostate-cancer therapy.
Pollock, TGen’s new associate investigator for melanoma research, will spend his time focusing on the factors that cause melanomas to develop. She previously worked in the cancer genetics branch at NHGRI.
Touchman, who will be the executive director of the DNA sequencing core, previously ran a sequencing center at NHGRI.
TGen has also appointed Dietrich Stephan as a senior research investigator and director of its neurogenomics program. Stephan previously served as co-director of Johns Hopkins’ University’s Children’s National Medical Center Microarray Center.
Additionally, Edward Suh, formerly of MIT and the NHGRI, is the CIO of TGen’s Center for Computational Bioscience, and Michael Berens, who has been a principal investigator in neuro-oncology at Phoenix’s Barrow Neurological Institute, will be the institute’s vice president of research.
Microarray software maker Silicon Genetics has appointed Gregory Kinch as vice president of sales and services.
Kinch comes to the Redwood City, Calif.-based company from Genomic Solutions, now a unit of Harvard Bioscience, where he was executive vice president of sales and marketing.